Maksim Labkouski SomaLogic’s (NASDAQ:SLGC) board of directors has issued an open letter to stockholders urging them to vote for a proposed merger with Standard Bio Tools (NASDAQ:LAB) and disputing allegations made by company’s founder that the deal was not properly negotiated. The board said the merger was in the best path forward for the company, asserting that SomaLogic’s co-development partnership with Illumina (ILMN) “will not guarantee the company’s success.” “With industry consolidation more broadly, and Illumina focused on its own set of priorities, it is paramount that SomaLogic strengthen its position in the market, and this transaction is the best way to accomplish this,” the letter said.

Maksim Labkouski SomaLogic（纳斯达克股票代码：SLGC）董事会向股东发出了一封公开信，敦促他们投票支持与标准生物工具（纳斯达克股票代码：LAB）的拟议合并，并对该公司创始人提出的交易未经适当谈判的指控提出质疑。董事会表示，合并是公司前进的最佳途径，并声称索玛洛奇与Illumina（ILMN）的合作开发伙伴关系“不会保证公司的成功。信中说：“随着行业整合范围的扩大，Illumina专注于自己的一系列优先事项，SomaLogic加强其在市场中的地位至关重要，这笔交易是实现这一目标的最佳方式。”。

The board also said that the proposed transaction was “the result of a thorough, independent and deliberative Board process,” and that board member Ed Casdin had recused himself from board discussions related to a potential deal with Standard Bio Tools. The board added that as part of a strategic review of the company’s options to maximize value for its stockholders, SomaLogic’s board engaged with 16 parties about a possible transaction, but only Standard Bio Tools “expressed any actionable indication of interest.” Standard BioTools was also the only party to sign a non-disclosure agreement, it said.

董事会还表示，拟议的交易是“董事会经过彻底、独立和审议的结果”，董事会成员埃德·卡斯丁（EdCasdin）回避了与标准生物工具（Standard Bio Tools）潜在交易相关的董事会讨论。董事会补充称，作为对公司股东价值最大化选择的战略审查的一部分，索玛洛奇董事会就可能的交易与16方进行了接触，但只有标准生物工具“表达了任何可行的利益迹象”。标准生物工具也是唯一签署保密协议的一方。

SomaLogic's board also noted that independent proxy advisory firm Institutional Shareholder Services has recommended that shareholders vote in favor of the merger. SomaLogic shareholders are scheduled to vote on the merger on Jan. 4. On Thursday, SomaLogic founder Larry Gold and Chief Technology Officer Jason Cleveland issued an open letter urging stockholders to vote against the proposed merger.

SomaLogic董事会还注意到，独立代理咨询公司机构股东服务（Institutional Holder Services）建议股东投票支持合并。SomaLogic股东计划于1月4日对合并进行投票。周四，SomaLogic创始人拉里·戈尔德（LarryGold）和首席技术官杰森·克利夫兰（JasonCleveland）发表了一封公开信，敦促股东投票反对拟议的合并。

The pair also accused the board of breaching its fiduciary responsiblities in n.

两人还指控董事会违反了其在n。